Your session is about to expire
← Back to Search
Behavioral Intervention
MindTrails for Anxiety in Huntington’s and Parkinson’s Disease
N/A
Waitlist Available
Led By Jessie S Gibson, PhD, RN
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of Huntington's disease or Parkinson's disease
Age 21 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between baseline and week 5
Awards & highlights
Study Summary
This trial will test a new web-based intervention to help reduce anxiety symptoms in people with Huntington's or Parkinson's disease.
Who is the study for?
This trial is for adults over the age of 21 who have been diagnosed with Huntington's disease or Parkinson's disease and are experiencing anxiety symptoms. Participants must score above 12 on the NeuroQoL Anxiety short form to qualify.Check my eligibility
What is being tested?
The study is testing 'MindTrails', a web-based program designed to help reduce anxiety symptoms in individuals with neurodegenerative movement disorders such as Huntington's and Parkinson's diseases.See study design
What are the potential side effects?
Since MindTrails is a non-pharmacological, cognitive-based intervention focused on modifying thought patterns, it may not have typical drug-related side effects but could potentially cause emotional discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Huntington's disease or Parkinson's disease.
Select...
I am 21 years old or older.
Select...
I experience significant anxiety symptoms.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ between baseline and week 5
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between baseline and week 5
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Participant perceptions of perceived benefits and limitations of MindTrails
Proportion of participants completing at least 50% of the MindTrails sessions
Trial Design
1Treatment groups
Experimental Treatment
Group I: MindTrails pilotExperimental Treatment1 Intervention
This intervention involves completion of five, 20-minute MindTrails online training sessions over five weeks.
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
748 Previous Clinical Trials
1,235,960 Total Patients Enrolled
Jessie S Gibson, PhD, RNPrincipal InvestigatorUniversity of Virginia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger